Pharmafile Logo
Pharmafocus logo
Advanced Search

Alzheimer’s

Showing 15 posts of 151 posts found.

Lundbeck’s Alzheimer’s drug shows promise

May 29, 2012
Research and Development, Sales and Marketing Alzheimer's, Lundbeck

Lundbeck’s Alzheimer’s candidate Lu AE58054 has shown signs in a phase II study of helping patients’ mental activity. Sufferers receiving …

News
Ian Read

Lipitor losses hit Pfizer

May 2, 2012
Sales and Marketing Alzheimer's, Lipitor, Pfizer, patent expiry

Lipitor’s US patent expiry has inflicted heavy damage on Pfizer’s revenues, with global sales down 7% in the first three …

News

Alzheimer’s diagnostic comes with caveats

April 10, 2012
Sales and Marketing Alzheimer's, Amyvid, lilly

A first-in-class test for Alzheimer’s disease has been approved by the FDA, but its makers have stressed its limitations.Lilly’s Amyvid …

News

UK government launches new dementia programme

March 26, 2012
Medical Communications, Sales and Marketing Alzheimer's, Cameron, UK, dementia

The government has signalled its intention to boost dementia funding and awareness with its new ‘challenge on dementia’ campaign.  In …

News
Teva image

Teva launches generic Aricept in the UK

February 16, 2012
Manufacturing and Production, Sales and Marketing Alzheimer's, Aricept, NHS, Pfizer, Teva

Teva has launched its generic version of Alzheimer’s drug Aricept, as the drug loses its patent protection in the UK.  …

News

AstraZeneca to take Alzheimer’s drug into phase II

January 5, 2012
Research and Development Alzheimer's, AstraZeneca, Targacept

AstraZeneca is to continue the development of Targacept’s AZD1446 as a treatment for Alzheimer’s disease.AZD1446 is a selective modulator of …

News

Nanoparticles to target Alzheimer’s disease

August 10, 2011
Research and Development Alzheimer's, nanoparticles

Researchers at Lancaster University funded by the European Union are hoping to develop a new treatment for Alzheimer’s disease. Nanoparticles …

News

Tangles and plaques: unlocking the secrets of Alzheimer’s disease

March 11, 2011
Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, bapineuzumab, dimebon, latrepirdine, solanezumab

Despite many years of relentless research efforts, Alzheimer’s disease, the most common form of dementia, remains impossible to cure. According …

Feature
Novo Nordisk's Victoza

Diabetes drugs show promise in Alzheimer’s

January 17, 2011
Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide

Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …

News

Biogen Idec buys neurodegenerative disease rights

December 21, 2010
Research and Development Alzheimer's, Alzheimer's disease, Alzheimer’s, Alzheimer’s disease, Biogen, Biogen IDEC, Neurimmune, Parkinson's disease, Parkinson’s disease, amyotrophic lateral sclerosis, neurodegenerative diseases

Biogen Idec has acquired a subsidiary of Swiss biotech company Neurimmune, and the rights to three pre-clinical immunotherapy drugs. The …

News

Europe’s neurologists unfamiliar with emerging Alzheimer’s drugs

November 17, 2010
Research and Development, Sales and Marketing Alzheimer's, Aricept, Decision Resources, Europe, Pfizer

A survey of neurologists in Europe has shown only a minority are aware of late stage drugs being developed to …

News
Images of a normal brain and an Alzheimer's brain

Alzheimer’s disease

October 16, 2010
Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Elan, J&J, JJ, Pfizer, lilly, pharmaceutical

In 1906 a psychiatrist working in a Frankfurt asylum became fascinated by the unnamed illness suffered by one of his …

Feature

Battle for Alzheimer’s drugs finally over

October 8, 2010
Sales and Marketing Alzheimer's, Aricept, NICE

NICE is to allow wider access to Alzheimer’s disease treatments, ending an epic five year battle for access to the …

News

NICE announces change of heart on Alzheimer’s

October 7, 2010
Sales and Marketing Alzheimer's, Aricept, Ebixa, Exelon, NICE, Reminyl

NICE is set to update its guidance on treatments for Alzheimer´s disease, widening access to four drugs. The draft guidance …

News

Nestlé to pioneer ‘health science nutrition’

September 29, 2010
Sales and Marketing Alzheimer's, health science nutrition, nestle

Nestlé is to take on conditions such as diabetes, obesity, cardiovascular disease and Alzheimer’s with the creation of two research …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025